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Significant progress has been made in recent years in terms of both the conceptualization of
neurotoxicity assessment strategies as well as in the development of behavioral techniques for
evaluating neurotoxic exposures. A tiered approach, for example, has been advocated as an
assessment strategy in which testing would proceed in a stepwise fashion from general screening
using simple behavioral methods and neuropathology (tier 1) to the characterization of effects (tier
2) using more specific testing techniques. With respect to tier-1 testing, behavioral observational
methods have been standardized for screening purposes, and these technically simple tech-
niques, together with automated methods for motor activity assessment, are being increasingly
incorporated into chemical and drug safety evaluations for regulatory purposes. With respect to
tier-2 testing, more technically sophisticated techniques and behavioral paradigms are available
for characterizing the behavioral effects of chemical exposures on motor, sensory, and cognitive
processes. Paradigms involving learned and unlearned behavior, for example, have been
described for quantifying a variety of clinical signs of motor impairment including paretic gait
disorders, tremor, and coordination deficits. Likewise, robust noninvasive behavioral methods
capable of tracking changes in visual, auditory, and somatosensory thresholds during the course
of exposure are also available. With respect to cognitive testing, numerous maze and operant
techniques and paradigms measuring different aspects of performance, learning, and memory
have been elaborated. This paper presents an overview of behavioral techniques currently used
to assess neurotoxicity in adult laboratory animals and discusses their application to hazard
identification and other areas of risk assessment. Environ Health Perspect 104(Suppl
2):317-322 (1996)
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Introduction
Neurotoxic effects ofchemicals, as reflected
by behavioral changes, have been known
through overexposure of humans and
lower animals since antiquity. The neuro-
toxic properties oflead, for example, were
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identified as early as 200 B.C., and the first
recorded regulatory measures in industrial
hygiene ever taken were aimed at protect-
ing workers from the neurological effects of
mercury exposure in the Idrian mines
in 1665 (1).
Over the last 100 years, industrial activ-
ities have introduced a vast array of new
chemicals into the home and environment
and have greatly increased the possibility of
toxic exposures in the general population.
At present, more than 65,000 chemicals are
commercially used by industry, including
some 3,350 pesticides, 8,627 food addi-
tives, 1,815 pharmaceuticals, and 3,410
cosmetic ingredcients (2,3). In addition,
more than 1,000 chemicals are introduced
into the market each year.
In reviewing the neurotoxicology
literature, Anger and Johnson (4) identi-
fied approximately 850 chemicals for
which there is some evidence for an adverse
effect on nervous system functioning and
behavior. Further, at the regulatory level,
maximum workplace exposure levels have
been established for 588 chemicals; ofthese,
167 have been regulated, at least in part, on
the basis oftheir effects on the nervous sys-
tem. In the United States alone, an esti-
mated 14 million persons are occupationally
exposed to these chemicals (5).
Despite the magnitude of neurotoxi-
cant exposures in working populations and
evidence that considerable amounts of
these chemicals are finding their way into
the environment, relatively few chemicals
have been even marginally evaluated for
their effects on nervous system function
and behavior (3). Although historically
morphologic and classical toxicologic meth-
ods have been used to provide evidence of
neurotoxicity, there has been increasing
acceptance ofthe use ofbehavioral meth-
ods in evaluating neurotoxicity (3,6). At
the regulatory level, the U.S. Environmental
Protection Agency (U.S. EPA) has pub-
lished generic neurotoxicity testing guide-
lines for the testing of chemicals and
pesticides (3), and the U.S. Food and Drug
Administration (FDA) is currently revising
its guidelines to include behavioral measures
ofneurotoxicity assessment (7). Further, on
an international level, the use ofbehavioral
methods for neurotoxicity assessment has
also been proposed by the Organization for
Economic Cooperation and Development
(OECD) (8).
Neurotoxicity Assessment
Strategies
Because ofthe heterogeneous nature ofthe
nervous system, different neurotoxic chemi-
cals can affect neurologic and behavioral
functioning in different, specific ways.
Thus, to evaluate the neurotoxicity of a
chemical, measures of different types of
functions are necessary. Further, for the pur-
pose ofregulatory testing, a number ofpan-
els and committees have recommended a
tiered approach to neurotoxicity assessment
(3,9,10). Such a tiered approach typically
involves a stepwise progression from general
screening using simple behavioral assess-
ment methods (functional observational
battery) and neuropathology, (tier 1)- to the
characterization of effects (tier 2) using
more specific behavioral, electrophysiologi-
cal, neurochemical, and neuropathological
techniques (6).
A functional observational battery (FOB)
consists ofa collection ofnoninvasive tests to
evaluate neurologic and behavioral signs in
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exposed animals (11,12). Usually, observa-
tions ofthe animal, which in most studies
is the rat, are carried out both while the rat
is in its home cage and while it is moving
freely about in a test arena for a specified
period of time. Animals are observed for
changes in arousal, reactivity to handling,
presence and type ofconvulsions, alterations
ofgait and mobility, and autonomic signs.
Several simple tests are also performed to
evaluate sensory functions (e.g., reactions to
noise, tactile stimulation, pain) as well as
motor functions (e.g., grip strength mea-
surements, landing foot splay). In regula-
tory testing, automated motor activity
assessment is also included in tier-I neuro-
toxicity screening.
Despite the apparent simplicity ofthese
tests, they have been shown to be quite sen-
sitive in detecting the neurotoxic effects ofa
number ofcompounds (11) and, indeed,
sometimes surpassing automated tech-
niques (13). Several issues that have been
repeatedly raised with respect to the use of
tier-I testing are the sensitivity of tests for
assessing sensory impairments as well as the
lack ofinclusion ofany tests at the screen-
ing level for measuring cognitive behavior
or learned performance.
In developing a test strategy in our own
laboratory, we have used simple tier-I tests,
as well as more sophisticated techniques, to
examine the neurotoxic effects ofa number
of compounds. In many cases, we often
used both simple and more specific behav-
ioral test methods in the same study rather
than applying a tiered-testing approach.
This has been especially true in chronic
studies of inhaled organic solvents (14),
where the costs ofexposing animals are high
relative to those associated with behavioral
testing. Further, despite the simplicity of
tier-I test methods, some techniques such as
grip-strength measurements show quite
acceptable levels of interanimal variability
and are quite stable in the same animal over
time. Thus, some ofthe techniques appro-
priate for tier-I screening in high-dose stud-
ies may also be sufficiendy sensitive for use
in long-term time-course studies at lower
doses. In addition, we also worked on the
development ofautomated tests ofsensory
function. The rationale for developing
auditory threshold measurements was based
on our failure to detect auditory dysfunc-
tion with simple tests ofstimulus reactivity
for compounds that are known ototoxic
agents. Finally,. given the reports in the
human literature on solvent effects and cog-
nitive functioning, our testing battery also
includes measures oflearned performance.
In this paper, an overview of these tech-
niques as well as those used by other inves-
tigators is presented.
Tests forQOantfifingClinical Signs of
MotorImpairment
The potential ofindustrial compounds to
affect motor function in humans is well doc-
umented (4,5), and manyofthe quantitative
neurobehavioral techniques thus far devel-
oped have concentrated on this functional
domain. Quantitative measurements ofgrip
strength, walking patterns, tremor, coordi-
nated movement, and motor activity have
all been successfully applied to evaluating
the effects ofchemical exposures on differ-
ent aspects ofmotor function (15).
One method for measuring neuro-
muscular function, which has become
widely used since its original description by
Meyer et al. (16), is the measurement of
fore- and hindlimb grip strength. Although
included in the U.S. EPA and proposed
OECD neurotoxicity testing guidelines as
a tier-I test, grip-strength measurements
are quite sensitive in detecting neuromus-
cular impairments, even at relatively low
exposure levels (15,17).
In our laboratory, the effects oflong-
term exposure to a number ofchemicals
including acrylamide, n-hexane, methyl-
mercury, and carbon disulfide have been
examined in studies lasting from 12 to 36
weeks (14,15). Examination ofthe stability
ofbaseline responding in control animals
and low variability ofthe data demonstrates
the sensitivity ofgrip-strength measurements
in detecting and quantifying the effects of
chemical agents that are toxic to peripheral
nerve, as well as the utility ofthis method in
extended exposure studies. These qualities,
together with low cost and ease ofadminis-
tration, make grip-strength measurements
suitable both for screening studies as well as
studies designed to evaluate the time course
ofeffects or mechanisms ofaction.
In addition to measures ofneuromuscu-
lar function, a number oftechniques have
been described for detecting and quantify-
ing disturbances ofgait and motor coordi-
nation. A simple and direct approach to
quantifying ataxic and paretic gait distur-
bances is the analysis ofrecords ofsuccessive
footprints made during locomotion (18).
To obtain a record offootprints while the
animal is in motion, the hindpaws are either
greased or inked and the animal is allowed
to walk on anonmoving,.paper-covered&sur-
face. To facilitate consistent walking in one
direction, testing is usually conducted by
placing the animal at one end ofa narrow
walkway covered with paper and allowing
it to traverse the length ofthe walkway to a
darkened enclosure at the other end. The
analysis ofgait topography has been applied
to evaluate a number ofdifferent types of
experimental treatments including drugs
(19), models ofperipheral nerve damage
and multiple sclerosis (20), and neurotoxic
agents. Recently, for example, Pryor (21)
used this type ofgait analysis in demon-
strating that high-level exposure to toluene
produces a persistent motor syndrome
marked by a shortened stride and a wide-
based gait analogous to that seen in heavy
toluene abusers.
Analysis ofsuccessive footfalls indicates
that stride length, stride width, and mea-
sures ofgait symmetry for normal adult rats
are highly consistent (22). There has been,
however, little standardization among labo-
ratories with respect to the exact procedures
used to collect footfall patterns. Further, it
is not yet known to what degree reduced
body size or weight may influence gait
topography. Thus, an approach similar to
that used by Pryor (21) for evaluating the
contribution ofbody size should probably
be adopted. One of the drawbacks ofgait
analysis is the large amount oftime neces-
sary to evaluate the hard-copy records.
However, the possibility ofusing computer-
supported analysis techniques has been
reported (23).
In addition to examining changes in gait
topographywhile the animal is walking on a
stationary surface, a number ofsimple and
complex techniques have been developed to
examine coordinated movement in other sit-
uations. The test oflanding foot splay, for
example, has been shown to be a relatively
stable and sensitive testofmotor impairment
(24) and has been incorporated into tier-I
testing methodologies. Other tests ofcoordi-
nated movement such as negative geotaxis
(17) and rotorod performance (25) appear
to be less reliable screening methods.
In our own laboratory, automated tech-
niques using a video-microprocessor system
have been developed for quantifying coor-
dination deficits in small animals and over-
come many of the problems seen with
rotorod testing. In initial studies using these
techniques, impaired motor function could
be demonstrated for a number ofdifferent
types of motor neurotoxicants including
short-term administration ofacrylamide,
ethanol, tremorine, and 2,5-hexanedione,
as well-as long-term inhalation exposure to
organic solvents (14,26).
Table 1 presents a comparison of the
effects ofa 12-week exposure to acrylamide
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Table 1. A summary of the effects of 12 weeks of
exposure to acrylamide on different measures of motor
impairment.
Significant
Tests and measures effects, p< First detected
Motor activity
Ambulation 0.005 Week 9
Rearing 0.002 Week 6
Grip strength
Forelimb 0.001 Week9
Hindlimb 0.001 Week 9
Coordination
Composite score 0.001 Week 6
Missteps 0.001 Week 6
Walking failure NS
Nerve conduction
Peak latency 0.001 Week 12
Peak amplitude 0.05 Week 12
Body weight NS
NS, not significant.
on different types of motor performance
measured in our laboratory. From these
data, it is obvious that any ofthe end points
measured, with the exception of body
weight andwalking failure, would have been
adequate for identifying acrylamide as a
neurotoxicant. However, there are obvious
differences in the time atwhich effects could
be detected. Although one may be tempted
to condude that the measurement ofrearing
and coordination by automated methods is
more sensitive, it may also be that different
effects develop with different time courses.
A further novel approach to measuring
coordinated movement employs an operant
paradigm involving wheel running for food
reward (27). In this study, changes in com-
plex motor behavior produced by methanol
were reflected in dose-related increases in
interresponse times ofwheel rotations, indi-
cating decreasing velocity with increasing
doses atlevels equal to 10% ofthe LD50.
In addition to changes in gait and coor-
dination, tremor is also an important clini-
cal sign ofneurotoxicant exposure. Tremor
refers to rhythmic, involuntary oscillations
ofthe whole body or a particular body part
and, as a clinical sign, is seen in various neu-
rological disease states, such as Parkinson's
disease and multiple sclerosis,-and as- a
consequence ofexposure to particular ther-
apeutic drugs or chemicals (28,29). In
addition, tremor can also result from envi-
ronmental overexposure to a variety ofcom-
pounds including metals, pesticides, and
organic solvents (4), and some ofthe most
dramatic instances ofhuman neurotoxic
disease have involved occupational expo-
sure to tremorogens. The only possibility
for detecting tremor using nonautomated
techniques is by visual observation. Several
methods for detecting and measuring
whole-body tremor using different types of
transducers have been described (30-32).
In addition to methods based on whole-
body tremor, operant techniques have been
used for examining the spectral profile of
tremorogenic agents (33,34). One inge-
nious technique employing operant proce-
dures to examine forelimb tremor in the rat
uses an operant chamber equipped with an
isometric force transducer as the operan-
dum. The force transducer is located in a
recessed aperture in such a way that the rat
must exert a predefined force on the trans-
ducer to gain access to the reinforcement
dipper. During response execution, oscilla-
tions ofthe rat's right forelimb detected by
the force transducer are recorded and ana-
lyzed to obtain spectral density functions
of tremor. Using this technique, Fowler
and his colleagues (34) reported frequency-
dependent changes in force oscillations in
haloperidol-treated rats. A similar use of
operant technology has also been described
for examining motor effects in primates;
this method appears to be quite sensitive in
detecting the onset ofmanganese-induced
motor impairment (33).
MotorActivityAssessment
Ofall the tests ofmotor function, measures
ofspontaneous activity have become the
behavioral parameters most extensively used
to examine the effects of neurotoxicant
exposures. Although some of the recent
focus on motoractivity may, in part, be due
to its proposed use as aregulatoryend point
for neurotoxicity screening, efforts to study
motor activity date back almost a century.
There are a number offeatures that make
motor activity an attractive behavioral end
point for examining the effects ofchemical
exposures. Motility is an inherent feature of
all animals, and motor activity occurs spon-
taneously without the need for deprivation
or pretraining ofthe animals. Further, mea-
sures ofmotor activity have been shown to
be sensitive to treatments known to affect
central nervous function, including brain
damage and drugs. Finally, the quanti-
fication of motor activity lends itself rela-
tively easily to automation, which is an
important consideration in a field ofstudy
in which the number ofcompounds that
are potentially worthy candidates for evalu-
ation can be expected to be substantial.
Motor activity assessment has been
extensively used in neurotoxicity assess-
ment; a number ofsurveys ofmethods and
critical reviews have been published over
the last 10 years examining different types
of automated motor activity assessment
techniques (14,35). Currently, the most
common methods use photocell detection
methods orvideoimaging techniques, which
can be used to track the animal. Motor
activity assessment is an apical test for
detecting neurotoxicant effects rather than
for documenting a specific clinical motor
effect. Although automated motor activity
assessment has been incorporated into tier-I
regulatory testing, it has also been used
together with other techniques for charac-
terizing behavioral changes during long-
term exposure in relation to blood and
brain levels oforganic solvents (36).
EvaluatingSensoryFunctions
Although a considerable amount ofimpor-
tance has been placed on the motor effects
of toxic exposures, possible effects on
sensory function are also ofgrowing con-
cern. Surveys of the literature have indi-
cated that approximately 44% ofchemicals
that possess neurotoxicant effects have an
impact on sensory function (37). The mea-
sures designed to evaluate sensory function
in the context oftier-I neurotoxicity testing
include simple tests ofreactivity to visual,
auditory, and somatosensory stimuli. Using
this approach, we have been unable to
obtain convincing data ofsensory impair-
ments for compounds that have been
described in the literature as toxic to the
visual or auditory nervous system. It may be
that this lack ofsensitivity is due to differ-
ences in dose or exposure duration and that
only a direct empirical comparison could
answer this question. However, ifone con-
siders the specific sensory effects described
in the literature, it is difficult to imagine
these observational methods being capable
ofdetecting specific hearing and visual
impairments (38).
Basically, two different types ofbehav-
ioral paradigms have been described for
evaluating sensory effects-those based on
operant conditioning and those using reflex-
modification techniques. Instrumental tech-
niques have induded the use ofboth active
avoidance paradigms as well as psychophys-
ical operant discrimination methodologies
in both rodents and primates.
One instrumental technique that has
been successfully used to uncover auditory
deficits in rats is the multisensory condi-
tioned avoidance paradigm (17,39). Using
this technique, Pryorandhis colleagues (39)
were able to uncover a neurotoxic effect not
previously noted with other methods,
namely, the ability oftoluene, xylene, and
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styrene to produce irreversible frequency-
specific hearing loss. Psychophysical oper-
ant discrimination techniques provide a
very elegant approach to the evaluation of
neurotoxicant-induced specific sensory
deficits. These techniques have been success-
fully used to examine toxicant effects on a
variety ofsensory processes including visual,
auditory, and somatosensory functions, as
well as the irritant properties ofvapors. A
number of reviews of this technology are
available (40,41). Some ofthe most elegant
studies using operant discrimination tech-
niques in primates demonstrate the selective
effects of neurotoxic agents such as acry-
lamide (42) and developmental methylmer-
cury exposure (43) on different aspects of
visual functioning.
One ofthe principal drawbacks usually
cited in discussions ofoperant sensory test-
ing paradigms is the relatively long periods
of time required to achieve stable baseline
levels ofresponding. Because ofthis limita-
tion, other authors have investigated the use
ofreflex-modification techniques as a possi-
ble tool both in terms ofscreening and char-
acterization ofsensory deficits, particularly
with respect to the auditorysystem (37).
The application of reflex-modification
procedures in rodents uses the whole-body
startle response, which reflexively occurs in
response to a sudden loud auditory stimu-
lus. The technique is based on the fact that
perceived stimuli presented shortly before
the startle stimulus will reduce the ampli-
tude of the startle response, which can be
measured as changes in downward force
with force transducers or other suitable
devices (44). By adapting the technique
using the eye-blink response rather than
the whole-body startle response, the tech-
nique can also be applied in human studies
(45). Reflex audiometry has been applied
to evaluating the ototoxic properties of a
number of drugs and chemicals including
ototoxic antibiotics (46), trimethyltin
(47), and trichloroethylene (48). One of
the disadvantages of reflex audiometry is
the relatively long testing sessions that are
required to obtain a full audiometric func-
tion across a wide range of frequencies.
However, it is also possible to limit the
number offrequencies tested in such a way
that reflex modification can also be used as
a screening method.
EvaluatingCangs inmLeaed
Performance and Cogniive Behaviors
Behavioral impairments indicative of
cognitive changes have been associated
with exposure to a number of chemicals.
Developmental exposure to lead (49),
methylmercury (50), and PCBs (51), for
example, have been causally related to
delayed development and intellectual
impairments in children. Further, chronic
exposure to organic solvents has been asso-
ciated with the development of toxic
encephalopathy and deficits in behavioral
performance at occupational exposure lev-
els (52). Given the fact that these and
other neurotoxicants are ubiquitous in the
environment, it is not surprising that con-
cern has been raised regarding the lack of
measures oflearning, memory, and behav-
ioral performance from tier-I testing in
the regulatory sphere.
There have been many models devel-
oped to evaluate different aspects oflearn-
ing and other higher-order functions in
animals. Some studies have concentrated
on the effects ofchemical exposures on the
performance oflearned behaviors, using,
for example, free operant techniques (53),
while others have attempted to develop
models to study acquisition and memory
(54). Further, a variety oftechniques (shut-
tle-box learning, maze techniques, and
operant techniques) have been used with
different behavioral paradigms including
active and passive avoidance learning,
reversal learning, repeated acquisition, and
delay tasks.
With respect to changes in the perfor-
mance oflearned behavior, schedule-con-
trolled operant behavior (SCOB) has been
extensively applied to the study ofdifferent
classes ofchemicals (55), and schedule-con-
trolled operant techniques for neurotoxicity
evaluation have been included in neurotoxi-
city testing guidelines. Because the aim of
many ofthe studies employing SCOB has
been to demonstrate the usefulness ofthese
methods in neurotoxicity screening, experi-
mental protocols used, for example, to
study inhaled organic solvents have typi-
cally employed high-level, short-duration
exposure schedules (56,57). Although such
studies can provide highly reliable quantita-
tive information bywhich to judge the rela-
tive potency of different compounds to
affect behavior in a given test system, they
also give the impression that very high con-
centrations of solvents are necessary to
affect learned behavior in rodents.
In our own laboratory, we have been
concerned with the effects of organic
solvents on psychomotor slowing in the
performance oflearned behavior. One of
the most consistent effects reported in the
human occupational literature is a slowing
in the performance on reaction-time tasks
in workers exposed to organic solvents.
Since most threshold limit values (TLVs)
for organic solvents have been chosen to
avoid acute behavioral effects ofthis nature
(14), it seemed worthwhile to determine
whether rats were also affected at occupa-
tionally relevant levels. Thus, we developed
an animal model ofa two-choice discrete-
trial operant task in the rat and examined
the levels at which effects on learned
performance began to occur. One of the
interesting findings in these studies is the
sensitivity of latency measures of this
method to the acute effects of low-level
exposure and the change in acute effects in
the context of repeated exposures (14).
Figure 1 shows the effects of inhalatory
exposure to perchloroethylene for 3 days
on the number of short-latency (<2 sec)
two-choice responses and the number of
long-latency responses. On day 1 ofexpo-
sure, performance was significantly affected
only in the high-concentration groups.
However, with repeated daily exposure,
effects also became apparent in the low-
dose groups as well. To what degree
changes in the acute effects of solvents
are related to changes in body burdens
with repeated exposure is currently being
investigated for compounds that produce
different effects in the short-term repeated
exposure situation.
In addition to the study of chemical
effects on the performance offree-operant
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Figure 1. The effects of perchloroethylene (PCE; 100,
350, 1225 ppm) on the number of short- and long-
latency responses in the performance of a discrete-trial
two-choice discrimination task.
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or discrete-trial tasks, a number ofinvesti-
gators have used different behavioral para-
digms to examine the effects ofchemicals on
learning and memory processes. Active and
passive avoidance tasks have been exten-
sively used in pharmacology for many years
to examine drug effects on acquisition learn-
ing and memory, and several advantages and
disadvantages ofthese approaches have been
discussed previously (54,58). One ofthe
principal drawbacks with the use ofthese
techniques is that they do not allow for the
repeated evaluation ofchanges in memory
or learning ability during the course of
long-term exposures.
One possible approach to studying
learning ability is the use of repeated
acquisition paradigms using either maze
tasks or operant chambers. Several repeated
acquisition paradigms have been described
in the literature using rodents including
reversal learning (59), repeated acquisition
ofresponse chains (60), and repeated acqui-
sition in mazes (61). Analogous approaches
for primates have also been described (62).
One of the primary advantages of using
repeated acquisition paradigms is the possi-
bility ofincorporating control measures into
the design ofthe task to distinguish changes
in general performance measures from those
related to acquisition (60). A similar
approach can also be employed in delayed
alternation and delayed matching tasks for
studying chemical effects on working
memory (54,63). The application ofmem-
ory and learning paradigms such as delayed
alternation, reversal learning, repeated
acquisition, and delayed-matching have
been applied for many years to study the
effects ofdrugs and brain lesions on learn-
ing and memory processes. To what degree
these techniques can be applied to neuro-
toxicology assessment is yet to be deter-
mined. However, the general approach
holds considerable promise for evaluating
neurotoxicant-induced effects on learning
and memory.
Concluding Remarks
To develop a comprehensive approach to
neurotoxicity assessment, the necessary tools
for evaluating the effects in question are
obviously ofutmost importance. Over the
last 10 years, significant advances have been
made in developing behavioral toxicology
assessment techniques, both simple and
complex. Methods for quantifying toxicant-
induced motor deficits that are sufficiently
sensitive and easy to perform have been
developed and can be used on a routine
basis for neurotoxicity screening. Although
detecting sensory changes is more com-
plex, the utility ofboth operant and reflex
methodologies have been demonstrated in
detecting sensory toxicants. With respect
to cognitive functions, one can expect con-
tinued refinements in techniques, which
will add incremental improvements to the
existing methodologies outlined above.
The availability of methodologies for
hazard identification, however, is only one
aspect ofa comprehensive assessment strat-
egy for evaluating the neurobehavioral
effects ofchemical exposures. Study designs
that address the role of different factors
such as toxicokinetics, concentration x time
relationships, sex and age differences, and
co-exposures, which contribute to the
expression ofneurotoxicity, are also ofcon-
siderable importance. In many cases, the
application oftechniques currently available
to these issues would be ofgreat value in
assessing the risk to human health posed by
chemical exposures.
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